April 4, 2011

Sanofi-Aventis said it completed its exchange offer for drug maker Genzyme, which expired just before midnight April 1.

March 7, 2011

The board of directors of Genzyme unanimously recommended that shareholders accept French drug maker Sanofi-Aventis’ $74-per-share buyout offer, Genzyme said Monday.

February 18, 2011

DEERFIELD, Ill. — Walgreens this month rounded out the pharmacy purchasing team led by Jeff Berkowitz, who joined the company in the fall as SVP pharmaceutical development and market access.


February 16, 2011

French drug maker Sanofi-Aventis will acquire U.S. biotech giant Genzyme for $20.1 billion, under an agreement the two companies announced Wednesday.

January 26, 2011

Watson Pharmaceuticals is seeking regulatory approval for a generic drug for high cholesterol.

January 20, 2011

Finalizing an acquisition of biotech company Genzyme by French drug maker Sanofi-Aventis “will take some time,” media reports quoted Genzyme’s chief executive as saying.

January 10, 2011

It appears that French drug maker Sanofi-Aventis’ efforts to acquire U.S. biotech company Genzyme are getting somewhere, according to company and media reports.

December 13, 2010

Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.

November 22, 2010

Impax confirmed a patent challenge for its version of a branded cholesterol drug that recently was submitted to the FDA for approval ...

November 17, 2010

Biotech company Genzyme Corp. is selling its diagnostics business to Sekisui Chemical Co. for $265...

October 7, 2010

The board of directors of Genzyme again has rejected a buyout offer by French drug...

October 7, 2010

The drug industry is undergoing a major paradigm shift. Companies that traditionally have relied on...

October 3, 2010

French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...

September 12, 2010

Laboratory Corp. of America Holdings will purchase a clinical testing business from Genzyme, Genzyme said...

August 30, 2010

After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday,...

August 29, 2010

Sanofi-Aventis is looking to acquire Genzyme with a nonbinding proposal valued at approximately $18.5 billion....

August 25, 2010

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

August 19, 2010

BioMarin Pharmaceutical has acquired privately owned biotechnology company ZyStor Therapeutics for $22 million, BioMarin said....

August 5, 2010

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...

August 2, 2010

French drug maker Sanofi-Aventis has made an offer for Genzyme, according to published reports....

July 12, 2010

Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of...

July 7, 2010

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...

July 5, 2010

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...

June 14, 2010

The Food and Drug Administration has agreed to speed up the review of a Genzyme...